Literature DB >> 24448812

[Cardiovascular and hemostaseological view of retinal vascular occlusions].

H Seidel1, E Stegemann, C Heiss.   

Abstract

BACKGROUND: Sudden pain-free impairment of vision often occurs due to acute occlusions of retinal blood vessels. Retinal vascular occlusion can be distinguished into the more frequent venous and to a lesser degree arterial events but mixed pictures also occur.
OBJECTIVES: Summary of the current literature regarding interdisciplinary diagnosis and therapy of retinal blood vessel occlusions.
MATERIALS AND METHODS: Selective literature review considering clinically relevant cardiovascular and hemostaseological aspects.
RESULTS: The anatomical localization of the occlusion by the ophthalmologist can give important indications for further medical diagnostic and therapeutic decisions. Arterial occlusions are mostly caused by thromboembolisms and the source should be identified and treated. Venous occlusions are mostly due to local processes with a prothrombotic background or venous stasis associated with arterial hypertension. Prognostically, the localization, extent and duration of retinal ischemia are decisive factors.
CONCLUSIONS: Vascular ocular occlusions are frequently secondary to internal disorders and therefore pose an interdisciplinary challenge.

Entities:  

Mesh:

Year:  2014        PMID: 24448812     DOI: 10.1007/s00347-013-2915-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  30 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

2.  Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.

Authors:  Anna Maria Gori; Rossella Marcucci; Cinzia Fatini; Francesca Gensini; Elena Sticchi; Andrea Sodi; Stefania Cappelli; Ugo Menchini; Gian Franco Gensini; Rosanna Abbate; Domenico Prisco
Journal:  Thromb Haemost       Date:  2004-07       Impact factor: 5.249

3.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

Review 4.  Prevalent misconceptions about acute retinal vascular occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2005-07       Impact factor: 21.198

5.  Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.

Authors:  W R Green; C C Chan; G M Hutchins; J M Terry
Journal:  Retina       Date:  1981       Impact factor: 4.256

Review 6.  Retinal vein occlusions: a review for the internist.

Authors:  Rossella Marcucci; Francesco Sofi; Elisa Grifoni; Andrea Sodi; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2010-12-14       Impact factor: 3.397

7.  Role of hyperhomocystinemia in retinal vascular occlusive disease.

Authors:  Gianluca Sottilotta; Vincenzo Oriana; Caterina Latella; Francesca Luise; Angela Piromalli; Francesca Ramirez; Corrado Mammi; Antonio Occhiuto; Vincenzo Trapani Lombardo
Journal:  Clin Appl Thromb Hemost       Date:  2007-01       Impact factor: 2.389

8.  High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion.

Authors:  Francesco Sofi; Rossella Marcucci; Sandra Fedi; Barbara Giambene; Andrea Sodi; Ugo Menchini; Gian Franco Gensini; Rosanna Abbate; Domenico Prisco
Journal:  Atherosclerosis       Date:  2009-11-10       Impact factor: 5.162

9.  Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

Authors:  Joel G Ray; Clive Kearon; Qilong Yi; Patrick Sheridan; Eva Lonn
Journal:  Ann Intern Med       Date:  2007-04-30       Impact factor: 25.391

10.  Streptokinase in central retinal vein occlusion: a controlled clinical trial.

Authors:  E M Kohner; J E Pettit; A M Hamilton; C J Bulpitt; C T Dollery
Journal:  Br Med J       Date:  1976-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.